Accessibility: Skip to content

Learn more about Risk-Sharing Agreements (RSA) from the interview with Medaffcon’s former employee Pekka Männistö from the video below.

RSA’s are one of the most interesting and debated topics in the Finnish Market Access scene at the moment. Medaffcon has been studying the agreements, their application and experiences in using them and has also been participating in building several agreements, both in ambulatory care (with Pharma Pricing Board) and hospital care (with hospitals).

More information:

Learn about conditional reimbursement from the interview with Jarmo Hahl, CEO, Medaffcon Oy.

Managed entry agreements facilitate the access of new medicines

 

Previous section:
Treatment

Next section:
Follow-up